Gonzalez B et al.Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide.Endocrinol Nutr 61:523-30 (2014).
Liu Y et al.Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment.Oncol Lett 6:821-828 (2013).
Ramírez C et al.Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.J Clin Endocrinol Metab 97:1745-51 (2012).
Fasciani A et al.Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions.J Clin Endocrinol Metab 95:5315-9 (2010).
Bruton JD et al.Increased fatigue resistance linked to Ca2+-stimulated mitochondrial biogenesis in muscle fibres of cold-acclimated mice.J Physiol 588:4275-88 (2010).
Righi L et al.Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases.Ann Oncol : (2009).
Volante M et al.Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy.Mod Pathol 20:1172-82 (2007).